Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Levonorgestrel × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Multiple Endocrine Neoplasia Type 1 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 37 Paclitaxel 35 Carboplatin 30 Bevacizumab 19 Specimen Handling 16 Letrozole 15 dostarlimab 12 Magnetic Resonance Spectroscopy 11 lenvatinib 10 Taxes 9 Fulvestrant 9 Biopsy 9 olaparib 8 abemaciclib 8 Nivolumab 8 Doxorubicin 8 Docetaxel 8 Cisplatin 8 atezolizumab 7 Observation 7 Blood Specimen Collection 6 palbociclib 5 niraparib 5 durvalumab 5 Megestrol Acetate 5 Gemcitabine 5 trastuzumab deruxtecan 4 ribociclib 4 Tirzepatide 4 Surveys and Questionnaires 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡